Tang, F., LeBlanc, M. E., Wang, W., Liang, D., Chen, P., Chou, T., . . . Li, W. (2019). Anti-secretogranin III therapy of oxygen-induced retinopathy with optimal safety. Angiogenesis, 22(3), 369-382. https://doi.org/10.1007/s10456-019-09662-4
Chicago-referens (17:e uppl.)Tang, Fen, Michelle E. LeBlanc, Weiwen Wang, Dan Liang, Ping Chen, Tsung-Han Chou, Hong Tian, och Wei Li. "Anti-secretogranin III Therapy of Oxygen-induced Retinopathy with Optimal Safety." Angiogenesis 22, no. 3 (2019): 369-382. https://doi.org/10.1007/s10456-019-09662-4.
MLA-referens (9:e uppl.)Tang, Fen, et al. "Anti-secretogranin III Therapy of Oxygen-induced Retinopathy with Optimal Safety." Angiogenesis, vol. 22, no. 3, 2019, pp. 369-382, https://doi.org/10.1007/s10456-019-09662-4.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
